[{"id":"1","description":"\"Harvard Pilgrim To Pay for 2 Autoimmune Drugs Based on Outcomes, Value\", Managed Care, 2017","date":"2018-07-25 11:20:31"}, {"id":"2","description":"Outcomes-Based Pharmaceutical Contracts: An Answer to High U.S. Drug Spending? Commonwealth Fund Issue Brief, September 2017","date":"2018-07-25 11:22:21"}, {"id":"3","description":"\"Developing a Path to Value-Based Payment for Medical Products; Value-Based Payment Advisory Group Kick-Off Meeting Background Paper\", Duke University, 2017","date":"2018-07-25 11:23:15"}, {"id":"4","description":"\"Health Insurers Push to Tie Drug Prices to Outcomes\", The Wall Street Journal, 2016","date":"2018-07-25 11:23:37"}, {"id":"5","description":"\"Developing a Path to Value-Based Payment for Medical Products; Value-Based Payment Advisory Group Kick-Off Meeting Background Paper\", Duke University, 2017; \"Harvard Pilgrim Signs Outcomes-Based Contracts with AstraZeneca for Brilinta and Bydureon\", BusinessWire (2017)","date":"2018-07-25 11:23:49"}, {"id":"6","description":"The U.S. OBIC Tracker, Stisali, updated May 2017","date":"2018-07-25 11:24:02"}, {"id":"7","description":"\"Harvard Pilgrim Signs Value-Based Contract with Eli Lilly & Company for its Osteoporosis drug, Forteo\", Metro Hartford Alliance","date":"2018-07-25 11:24:19"}, {"id":"8","description":"Performance-Based Risk-Sharing Arrangements for Pharmaceutical Products in the United States: A Systematic Review","date":"2018-07-25 11:24:35"}, {"id":"9","description":"\"Overcoming Challenges of Outcomes-Based Contracting for Pharmaceuticals: Early Lessons from the Genentech - Priority Health Pilot\", Health Affairs Blog, 2017","date":"2018-07-25 11:24:52"}, {"id":"10","description":"\"Aetna and Merck Sign a Unique Value-Based Contract to Januvia and Janumet\", Aetna Press Release, October 2016","date":"2018-07-25 11:25:10"}, {"id":"11","description":"Developing a Path to Value-Based Payment for Medical Products; Value-Based Payment Advisory Group Kick-Off Meeting Background Paper, 2017","date":"2018-07-25 11:25:24"}, {"id":"12","description":"http:\/\/www.news.sanofi.us\/2018-05-01-Sanofi-and-Regeneron-to-lower-net-price-of-Praluent-R-alirocumab-Injection-in-exchange-for-straightforward-more-affordable-patient-access-for-Express-Scripts-patients https:\/\/www.cnbc.com\/2018\/05\/01\/regeneron-sanofi-chop-cholesterol-drug-price-in-express-scripts-pact.html","date":"2018-07-25 11:25:43"}, {"id":"13","description":"Outcomes-Based Contracts Offer Payers New Pharmaceutical Options,HealthPayer Intelligence, 2018; Spark Therapeutics Press Release, Jan 2018","date":"2018-07-25 11:25:54"}]